Ocular manifestations of the autoinflammatory syndromes

REFERENCES

• Abbas AK, Lichtman AH. Basic Immunology: Functions and Disorders of the Immune System. Philadelphia, PA: Saunders, 2008.
   Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1–14.
   PubMed Web of Science ®Google Scholar
• Huysamen C, Brown GD. The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol Lett 2009 Jan;290 (2):121–128.
   PubMedGoogle Scholar
• Yoneyama M, Fujita T. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev 2007 Oct- Dec;18 (5–6):545–551.
   PubMedGoogle Scholar
• Onomoto K, Onoguchi K, Takahasi K, Fujita T. Type I interferon production induced by RIG-I-like receptors. J Interferon Cytokine Res 2010 Dec;30 (12):875–881.
   PubMedGoogle Scholar
• Schmidt A, Endres S, Rothenfusser S. Pattern recognition of viral nucleic acids by RIG-I-like helicases. J Mol Med (Berl) 2011 Jan;89 (1):5–12.
   PubMedGoogle Scholar
• Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007 Jul 26;448 (7152):501–505.
   PubMedGoogle Scholar
• Fantuzzi G, Dinarello CA. The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J Leukoc Biol 1996;59:489–489.
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Fitzgerald KA. Innate immune sensing of DNA viruses. Virology 2011 Mar 15;411 (2):153–162.
   PubMedGoogle Scholar
• Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006 Jul 6;442 (7098):39–44.
   PubMedGoogle Scholar
• Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327:291–295.
   PubMed Web of Science ®Google Scholar
• Burns K, Martinon F, Esslinger C, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998; 273:12203–12209.
   PubMed Web of Science ®Google Scholar
• Franchi L, Warner N, Viani K, Nuñez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009;227:106–128.
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005;26:447–454.
   PubMed Web of Science ®Google Scholar
• Drenth JP, van der Meer JWM. The inflammosome—a linebacker of innate defense. N Engl J Med 2006;355:730–732.
   PubMed Web of Science ®Google Scholar
• Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821–832.
   PubMed Web of Science ®Google Scholar
• Kuida K, Lippke JA, Ku G, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995;267:2000–2003.
   PubMed Web of Science ®Google Scholar
• Pedra JH, Sutterwala FS, Sukumaran B, et al. ASC/PYCARD and caspase-1 regulate the IL-18/IFN-gamma axis during Anaplasma phagocytophilum infection. J Immunol 2007;179:4783–4791.
   PubMedGoogle Scholar
• Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002;80:147–162.
   PubMedGoogle Scholar
• Jang WC, Park SB, Nam YH, et al. Interleukin-18 gene polymorphisms in Korean patients with Behçet’s disease. Clin Exp Rheumatol 2005;23 (4 Suppl. 38):S59–63.
   Google Scholar
• Ohno T, Oboki K, Kajiwara N, Morii E, Aozasa K, Flavell RA, Okumura K, Saito H, Nakae S. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol 2009 Dec 15;183 (12):7890–7897.
   PubMedGoogle Scholar
• Hong J, Bae S, Jhun H, Lee S, Choi J, Kang T, Kwak A, Hong K, Kim E, Jo S, Kim S. Identification of constitutively active interleukin 33 (IL-33) splice variant. J Biol Chem 2011 Jun 3;286 (22):20078–20086.
   PubMedGoogle Scholar
• Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010;10:103–110.
   PubMed Web of Science ®Google Scholar
• Verhaeghe B, Gevaert P, Holtappels G, et al. Up-regulation of IL-18 in allergic rhinitis. Allergy 2002;57:825–830.
   PubMed Web of Science ®Google Scholar
• Matsuda A, Okayama Y, Terai N, et al. The role of interleukin-33 in chronic allergic conjunctivitis. Invest Ophthalmol Vis Sci 2009;50:4646–4652.
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Weiss DS, Newton K, et al. Cryopyrin activates the inflammasome in response to toxins an ATP. Nature 2006;440:228–232.
   PubMed Web of Science ®Google Scholar
• Martinon F, Petrilli V, Mayor A, et al. Gout-associated urinc acid crystals activate the NALP3 inflammasome. Nature 2006;440:237–241.
   PubMed Web of Science ®Google Scholar
• Dostert C, Petrilli V, Van Bruggen R, et al. Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science 2008;320:674–677.
   PubMed Web of Science ®Google Scholar
• Halle A, Hornung V, Petzold GC, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008;9:857–865.
   PubMed Web of Science ®Google Scholar
• Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464:1357–1361.
   PubMed Web of Science ®Google Scholar
• Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010 Jan 15;327 (5963):296–300.
   PubMedGoogle Scholar
• Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Ann Rev Immunol 2009;27:229–265.
   PubMed Web of Science ®Google Scholar
• Aróstegui JI, Aldea A, Modesto C, et al. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum 2004;50:4045–4050.
   PubMed Web of Science ®Google Scholar
• Kurakawa T et al. Ocular manifestations in Blau syndrome associated with a CARD15/NOD2 mutation. Ophthalmology 2003;110:2040.
   Google Scholar
• Snyers B, Dahan K. Blau syndrome associated with a CARD15/NOD2 mutation. Am J Ophthalmol 2006;142:1089–1092.
   PubMedGoogle Scholar
• Martin TM, Zhang Z, Kurz P, et al. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum 2009;60:611–618.
   PubMedGoogle Scholar
• Arostegui JI, Arnal C, Merino R, et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 2007;56:3805–3813.
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn disease. Nature 2001;411:599–603.
   PubMed Web of Science ®Google Scholar
• Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn disease in German and British populations. Lancet 2001;357:1925–1928.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn disease. Nature 2001;411:603–606.
   PubMed Web of Science ®Google Scholar
• Martin TM, Doyle TM, Smith JR, et al. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 2003;135:933–935.
   Google Scholar
• Gonzalez-Benitez JF, Juarez Verdayes MA, Rodriguez-Martinez S, et al. The NALP3/Cryopyrin-inflammasome complex is expressed in LPS-induced ocular inflammation. Mediators Inflamm 2008;1–7.
   Google Scholar
• Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009;360:2426–2437.
   PubMed Web of Science ®Google Scholar
• Jéru I, Marlin S, Le Borgne G, et al. Functional consequences of a germline mutation in the leucine-rich repeat domain of NLRP3 identified in an atypical autoinflammatory disorder. Arthritis Rheum 2010;62:1176–1185.
   PubMedGoogle Scholar
• Jéru I, Duquesnoy P, Fernandes-Alnemri T, et al. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci USA 2008;105:1614–1619.
   PubMed Web of Science ®Google Scholar
• Jéru I, Hayrapetyan H, Duquesnoy P, Sarkisian T, Amselem S. PYPAF1 nonsense mutation in a patient with an unusual autoinflammatory syndrome: role of PYPAF1 in inflammation. Arthritis Rheum 2006;54:508–514.
   PubMedGoogle Scholar
• Ferretti M, Gattorno M, Chiocchetti A, et al. The 423Q polymorphism of the X-linked inhibitor of apoptosis gene influences monocyte function and is associated with periodic fever. Arthritis Rheum 2009;60:3476–3484.
   PubMedGoogle Scholar
• Jeru I, Le Borgne G, Cochet E, et al. Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes. Arthritis Rheum 2011;63:1459–1464.
   PubMed Web of Science ®Google Scholar
• Borghini S, Tassi S, Chiesa S, et al. Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation. Arthritis Rheum 2011;63:830–839.
   PubMedGoogle Scholar
• McDermott, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97:133–144.
   PubMedGoogle Scholar
• Prieur AM, Griscelli C. Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr 1981;99:79–83.
   PubMed Web of Science ®Google Scholar
• Prieur AM, Griscelli C, Lampert F, et al. A chronic infantile, neurological, cutaneous and articular (CINCA) syndrome: a specific entity analysed in 30 patients. Scand J Rheumatol Suppl 1987;66:57–68.
   PubMedGoogle Scholar
• Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002 Dec;46 (12):3340–3348.
   PubMed Web of Science ®Google Scholar
• Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002 Jul;71 (1):198–203.
   PubMed Web of Science ®Google Scholar
• Torbiak RP, Dent PB, Cockshott WP. NOMID: a neonatal syndrome of multiystem inflammation. Skeletal Radiol 1989;18:359–364.
   PubMedGoogle Scholar
• Hashkes PJ, Lovell DJ. Recognition of infantile-onset multisystem inflammatory disease as a unique entity. J Pediatr 1997;130:513–515.
   PubMed Web of Science ®Google Scholar
• Dollfus H, et al. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol 2000;118:1386–1392.
   PubMedGoogle Scholar
• Hawkin PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to Anakinra. Arthritis Rheum 2004;50:607–612.
   PubMedGoogle Scholar
• Shakeel A, Gouws P. Muckle-Wells syndrome: another cause of acute anterior uveitis. Eye 2007;21:849–850.
   PubMedGoogle Scholar
• Dodé C, André M, Bienvenu T, et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002;46:2181.
   PubMedGoogle Scholar
• The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997 Aug 22;90 (4):797–807.
   Google Scholar
• French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997 Sep;17 (1):25–31.
   Google Scholar
• El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet 2006;367:1016–1024.
   PubMed Web of Science ®Google Scholar
• Lange-Sperandio B, Möhring K, Gutzler F, Mehls O. Variable expression of vasculitis in siblings with familial Mediterranean fever. Pediatr Nephrol 2004 May;19 (5):539–543.
   PubMedGoogle Scholar
• Jabs DA, Houk JL, Bias WB, Arnett FC. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med 1985 May;78 (5):801–804.
   PubMedGoogle Scholar
• Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr 1985;107:689–693.
   PubMed Web of Science ®Google Scholar
• Rosé CD, Wouters CH, Meiorin S, et al. Pediatric granulomatous arthritis: an international registry. Arthritis Rheum 2006;54:3337–3344.
   PubMed Web of Science ®Google Scholar
• Latkany PA, Jabs DA, Smith JR, et al. Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. Am J Ophthalmol 2002;134:897–904.
   PubMedGoogle Scholar
• Gül A. Behçet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005 Feb;4 (1):81–83.
   PubMedGoogle Scholar
• Nara K, Kurokawa MS, Chiba S, Yoshikawa H, Tsukikawa S, Matsuda T, Suzuki N. Involvement of innate immunity in the pathogenesis of intestinal Behçet’s disease. Clin Exp Immunol 2008 May;152 (2):245–251.
   PubMedGoogle Scholar
• Yazici H, Fresko I. Behçet’s disease and other autoinflammatory conditions: what’s in a name? Clin Exp Rheumatol 2005 Jul–Aug;23(4 Suppl. 38):S1–2.
   PubMedGoogle Scholar
• Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behçet’s disease. Hum Mutat 2000 Sep;16 (3):271–272.
   PubMedGoogle Scholar
• Livneh A, Aksentijevich I, Langevitz P, et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet’s disease (FMF-BD). Eur J Hum Genet 2001 Mar;9 (3):191–196.
   PubMedGoogle Scholar
• Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behçet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003 Jul–Aug; 21(4 Suppl. 30):S35–37.
   Google Scholar
• Rabinovich E, Shinar Y, Leiba M, et al. Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 2007 Jan–Feb;36 (1):48–52.
   PubMedGoogle Scholar
• Gul A, Inanc, M, Ocal L, et al. Familial aggregation of Behcet’s disease in Turkey. Ann Rheumatic Diseases 2000;59:622–625.
   PubMed Web of Science ®Google Scholar
• Levy-Clarke GA, Nussenblatt RB, Smith JA. Management of chronic pediatric uveitis. Curr Opin Ophthalmol 2005;16:281–288.
   PubMedGoogle Scholar
• Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1B inhibition. N Engl J Med 2006;355:581–592.
   PubMed Web of Science ®Google Scholar
• Hawkins PN, Lachmann HJ, McDermott MF. Interleukin1-receptor antagonist in Muckle-Wells syndrome. N Engl J Med 2003;348:2583–2584.
   PubMed Web of Science ®Google Scholar
• Sibley CH, Plass N, Snow J, et al. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease (NOMID) treated with anakinra. Arthritis Rheum 2012 Jan 31. doi: 10.1002/art.34409. [Epub ahead of print].
   PubMedGoogle Scholar
• Alexander T, Klotz O, Feist E, et al. Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist. Ann Rheum Dis 2005;64:1245–1246.
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Thorne ML, Amar NJ, et al. Efficacy and safety of rilonacept (interleukin01 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008;58:2443–2452.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009;360:2416–2425.
   PubMed Web of Science ®Google Scholar
• Hoffman HM. Therapy of autoinflammatory syndromes. J Allergy Clin Immunol 2009;124:1129–1138.
   PubMed Web of Science ®Google Scholar
• Milman N, Andersen CB, Hansen A, et al. Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 2006 Dec;114 (12):912–919.
   PubMed Web of Science ®Google Scholar
• Yasui K, Yashiro M, Tsuge M, et al. Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism. Arthritis Rheum 2010 Jan;62 (1):250–257.
   PubMed Web of Science ®Google Scholar